← Back to Clinical Trials
Recruiting NCT07181863

NCT07181863 Technology-Enabled Collaborative Care for Diabetes and Mental Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07181863
Status Recruiting
Phase
Sponsor McMaster University
Condition Type 2 Diabetes
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-03-16
Primary Completion 2027-12

Trial Parameters

Condition Type 2 Diabetes
Sponsor McMaster University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-03-16
Completion 2027-12
Interventions
Health coachingEducational emails

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Managing both type 2 diabetes and mental health challenges can be difficult, and many people do not receive care that supports both. This study looks at how virtual health coaching and support from interdisciplinary care teams can help people better manage their health. The purpose of this study is to test the effectiveness of a virtual health coaching program for adults living with type 2 diabetes and mental health challenges compared to usual care. The Technology-Enabled Collaborative Care for type 2 Diabetes and Mental health (TECC-DM) program includes weekly coaching calls, support from an interdisciplinary care team, and online tools to aid self-management. The findings from this study will be used to help improve services for people who have type 2 diabetes and co-occurring mental health symptoms.

Eligibility Criteria

Inclusion Criteria: * Adults ≥18 years old * Diagnosed with type 2 diabetes (T2D) * Experiencing mental health challenges, defined as: * Hospital Anxiety and Depression Scale (HADS) score ≥8 on either subscale OR * Diabetes Distress Scale (DDS) score ≥2 * Community-living * Able to communicate verbally in English * Residing in Ontario during study participation Exclusion Criteria: * Diagnosis of severe mental illness (e.g., schizophrenia, psychotic disorder)

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology